September 10, 2021
Dr. Steven Grover has been selected as on of the top reviewers for ATVB in 2021. He will be recognized during the ATVB Journal Editorial Board Meeting in November 2021. The ATVB journal relies on the time and effort of many dedicated reviewers. Among these many individuals, the journal recognizes those that have made extraordinary …
August 30, 2021
UNC Blood Research Center’s contribution to research~ BRC member and Conference organizer Dr. Matthew Flick will Chair the conference being held February 6-11, 2022. Plasminogen Activation and Extracellular Proteolysis, Gordon Research Conference Mechanisms and Therapeutic Targets of Extracellular Proteolysis in Human Disease February 6 – 11, 2022 Apply Now Chairs Matthew Flick and Tetsumei …
August 18, 2021
Drs. Matthew Flick, PhD and Alisa Wolberg, PhD of the UNC Blood Research and faculty within the Department of Pathology and Laboratory Medicine have been awarded a $2.3 million, 4-year R01 grant from the NIH-NHBLI to investigate the mechanisms by which the plasminogen activation system and the blood clotting protein fibrinogen affect the pathogenesis of …
August 10, 2021
Congratulations to Robert Lee, PhD Dr. Lee was awarded a 2-year basic science grant from the Ehlers-Danlos Society entitled “Investigating Intrinsic Platelet Dysfunction in Ehlers-Danlos Syndrome”. The main objective of the project is to understand the contribution of impaired platelet function to bleeding in Ehlers Danlos Syndrome, a group of inherited connective tissue disorders with …
July 26, 2021
Public Health Webinar Series on Blood Disorders BRINGING SCIENCE INTO PRACTICE The Division of Blood Disorders is proud to offer this webinar series, providing evidence-based information on new research, emerging issues of interest in blood disorders, as well as innovative approaches to collaboration. Hereditary Hemorrhagic Telangiectasia in 2021: Diagnosis and Advances in Treatment August 19, …
July 15, 2021
A Multi-center Prospective Cohort Study in Adults with Sickle Cell Disease suggests that infusion centers give faster, more patient-centered symptom relief for people with sickle cell disease. Efforts ongoing to apply these lessons locally! 269 people with Sickle cell disease, followed at 4 US sites, were evaluated for treatment outcomes after being seen for management …
June 17, 2021
Congratulations Tina Abrams for being honored twice at the Department of Pediatrics Award Day. Tina was honored for her stellar research presentation at the Day of Scholarship in May. She earned the award for Best Basic Science Presentation as well Best Overall Research. Tina is currently part of Dr. Rafal Pawlinski’s Lab in the UNC …
April 29, 2021
We might never know the answer to these specific questions, but we should continue to document realworld findings, particularly regarding the risks and benefits of voxelotor to end-organ function. Building on preclinical models,7 preliminary studies showing preserved or lowered cerebral blood flow,8 together with the results of this study1 and ongoing studies, such as HOPE …
April 16, 2021
UNC is now a fully active clinical site for the ACTIV-4c Post-Hospital Thrombosis Prevention Study, led at UNC-Chapel Hill by Raj Kasthuri, MBBS, Professor of Medicine. This protocol is part of the larger ACTIV (Accelerating COVID-Therapeutic Interventions and Vaccine) study. Raj Kasthuri, MBBS UNC is now a fully active clinical site for the ACTIV-4c …
April 8, 2021
Michael Henderson, PhD, Key lab of the Blood Research Center has first author publication: Abstract Acetaminophen (APAP)-induced liver injury is associated with activation of coagulation and fibrinolysis. In mice, both tissue factor-dependent thrombin generation and plasmin activity have been shown to promote liver injury after APAP overdose. However, the contribution of the contact and intrinsic …
April 7, 2021
Two members of the UNC Blood Research Center, Rafal Pawlinski PhD and Nigel Key MD, both Professors in the Department of Medicine, Division of Hematology, have been awarded a $2.8 million, 4-year RO1 grant from the NIH-NHLBI to investigate the mechanism of venous thromboembolism (VTE) in sickle cell disease (SCD). Dr. Rafal Pawlinski and Dr. …
March 9, 2021
UNC Blood Research Center to sponsor HTRS Travel Awards! HTRS provides grants to support up to $1,500 in travel and lodging, plus complimentary meeting registration fees for young investigators who submit the highest scoring abstracts to be displayed as posters at HTRS Scientific Symposia. HTRS 2021 Scientific Symposium – Virtual Event March 8 @ 12:30 …